Details for Patent: 8,637,451
✉ Email this page to a colleague
Summary for Patent: 8,637,451
Title: | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
Abstract: | A method of treatment of inflamed, pre-cancerous or cancerous tissue or polyps in a mammalian subject is disclosed. The treatment involves administration of a composition of at least one peptide agonist of a guanylate cyclase receptor and/or other small molecules that enhance intracellular production of cGMP. The at least one peptide agonist of a guanylate cyclase receptor may be administered either alone or in combination with an inhibitor of cGMP-dependent phosphodiesterase. The inhibitor may be a small molecule, peptide, protein or other compound that inhibits the degradation of cGMP. Without requiring a particular mechanism of action, this treatment may restore a healthy balance between proliferation and apoptosis in the subject's population of epithelial cells, and also suppress carcinogenesis. Thus, the method may be used to treat, inter alia, inflammation, including gastrointestinal inflammatory disorders, general organ inflammation and asthma, and carcinogenesis of the lung, gastrointestinal tract, bladder, testis, prostate and pancreas, or polyps. |
Inventor(s): | Shailubhai; Kunwar (Audubon, PA), Nikiforovich; Gregory (St. Louis, MO), Jacob; Gary S. (New York, NY) |
Assignee: | Synergy Pharmaceuticals Inc. (New York, NY) |
Application Number: | 13/339,785 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,637,451 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,637,451
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,637,451
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2441970 | ⤷ Try a Trial | |||
Canada | 2795396 | ⤷ Try a Trial | |||
Canada | 2905585 | ⤷ Try a Trial | |||
China | 102643333 | ⤷ Try a Trial | |||
China | 103638514 | ⤷ Try a Trial | |||
China | 103641892 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |